These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7145882)

  • 41. [Gas chromatographic determination of phospholipid fatty acids and free cholesterol in a single sample].
    Briuzgina TS; Kravchenko EIa; Donish AV
    Lab Delo; 1991; (9):18-20. PubMed ID: 1721946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A clinico-pathogenetic assessment of the membrane structure and functions of the peripheral blood lymphocytes in insulin-dependent diabetes mellitus].
    Nelaeva AA; Kashuba EA; Kardakov IuI
    Probl Endokrinol (Mosk); 1990; 36(5):24-8. PubMed ID: 2127844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Erythrocyte lipids in diabetes mellitus with vascular involvement].
    Kasimova GM; Mirtalipov DT; Abidov AA; Akbarov ZS
    Vopr Med Khim; 1989; 35(3):42-7. PubMed ID: 2773383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [ADP-induced aggregation of human platelets in diabetes mellitus].
    Chirkov IuIu; Tyshchiuk IA; Severina IS; Starosel'tseva LK
    Vopr Med Khim; 1990; 36(4):20-2. PubMed ID: 2238525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary modifications of plasma cholesterol and phospholipid levels in diabetic patients; the effects of mixed diets high in vegetable fat.
    COCHRANE GC; MICHAELS GD; KINSELL LW
    J Clin Nutr; 1953; 1(4):295-8. PubMed ID: 13061603
    [No Abstract]   [Full Text] [Related]  

  • 46. Critique of a biologic mechanism linking calcium antagonists to increased risk for cardiovascular events in diabetes.
    Mason RP; Mason PE
    Am J Cardiol; 1998 Nov; 82(9B):29R-31R. PubMed ID: 9822141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets.
    Ulibarrena C; Vecino A; Cesar JM
    Br J Haematol; 1994 Jul; 87(3):614-6. PubMed ID: 7993804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interrelationships of the individual plasma phospholipids and cholesterol in health and in long-term diabetes mellitus.
    PETERSEN VP
    Acta Med Scand; 1953; 146(5):375-83. PubMed ID: 13091750
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinico-statistical study on the behavior of hemogenic tests and of the platelets in diabetes mellitus].
    LASAGNA GC; TEDESCHI G; ALBERINI B; SCHIAVI L
    Riforma Med; 1961 Jul; 75():765-70. PubMed ID: 13759236
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification of phospholipids in human thrombocytes and erythrocytes.
    BLOMSTRAND R; NAKAYAMA F; NILSSON IM
    J Lab Clin Med; 1962 May; 59():771-8. PubMed ID: 13870104
    [No Abstract]   [Full Text] [Related]  

  • 51. [Quantitative and qualitative changes in the sex chromatin of diabetic women of different ages].
    Kaiumov EG; Dmitrieva EN
    Probl Endokrinol (Mosk); 1975; 21(5):7-9. PubMed ID: 1228754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phospholipid metabolism in diabetes; turnover rate of plasma phospholipids in completely depancreatized dogs.
    CHAIKOFF IL; ZILVERSMIT DB; ENTENMAN C
    Proc Soc Exp Biol Med; 1948 May; 68(1):6-9. PubMed ID: 18863660
    [No Abstract]   [Full Text] [Related]  

  • 53. Phospholipid utilization in the diabetic dog.
    HAPER PV; NEAL WB; ROGERS GR
    Proc Soc Exp Biol Med; 1948 Jun; 68(2):363-9. PubMed ID: 18869350
    [No Abstract]   [Full Text] [Related]  

  • 54. Relation of blood thromboplastin activity to its total phospholipid content.
    BENTLEY HP; KRIVIT W
    Proc Soc Exp Biol Med; 1962 Mar; 109():530-3. PubMed ID: 13867379
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter by Jin-shan and Xue-bin Regarding Article, "Platelets Express Activated P2Y
    Jin-Shan H; Xue-Bin L
    Circulation; 2018 Apr; 137(17):1874. PubMed ID: 29685938
    [No Abstract]   [Full Text] [Related]  

  • 56. [Synergism and antagonism of purified phospholipid fractions in thromboplastinogenesis].
    TURPINI R; CIPOLLI PL; MOSSA A
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1320-2. PubMed ID: 13923263
    [No Abstract]   [Full Text] [Related]  

  • 57. Chromatographic analysis of phospholipid and cholesterol oxidation.
    Krull UJ; Thompson M; Arya A
    Talanta; 1984 Jul; 31(7):489-95. PubMed ID: 18963636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A modified method for the estimation of phospholipid in blood.
    NATH RL; CHATTERJI A
    Ann Biochem Exp Med; 1962 Feb; 22():31-6. PubMed ID: 14478513
    [No Abstract]   [Full Text] [Related]  

  • 59. [The problem of the oncospecific phospholipid, 'malignolipin." Oncodiagnostic value of its detection in the blood].
    ALBERTINI E; DELLA VOLPE R; MERLI G
    Minerva Med; 1962 May; 53():1466-78. PubMed ID: 13860135
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the presence of neutral fats in normal and pathological human thrombocytes].
    JEAN G; RACINE L; MARX R; GAUTIER A
    Thromb Diath Haemorrh; 1963 Apr; 9():1-11. PubMed ID: 14041902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.